Pair of R&D updates bolster GSK ahead of investor meeting

Pair of R&D updates bolster GSK ahead of investor meeting

Source: 
Pharmaforum
snippet: 

GlaxoSmithKline (GSK) has reported encouraging data for its COVID-19 antibody sotrovimab, and an alliance with Halozyme to develop a new generation of long-acting HIV drugs, as it prepares to give a much-anticipated update to shareholders tomorrow.